Sarah Condella - Apr 3, 2023 Form 4 Insider Report for EXACT SCIENCES CORP (EXAS)

Role
EVP, Human Resources
Signature
/s/ Sarah Condella by Mark R. Busch, attorney-in-fact
Stock symbol
EXAS
Transactions as of
Apr 3, 2023
Transactions value $
-$67,190
Form type
4
Date filed
4/5/2023, 04:10 PM
Previous filing
Mar 2, 2023
Next filing
May 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EXAS Common Stock Sale -$67.2K -1K -1.14% $67.19 86.7K Apr 3, 2023 Direct F1, F2
holding EXAS Common Stock 5.43K Apr 3, 2023 Held in 401(k) Plan
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sale reported in this field was effected pursuant to a Rule 10b5-1 trading plan entered into on February 28, 2022.
F2 In addition to the shares of Common Stock reported on this Form 4, which total 92,117 shares, Ms. Condella also holds, in the aggregate, an additional 85,425 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock.